News

intracranial aneurysm, endovascular treatment, EVT, MRA, Naggara

Endovascular treatment (EVT) of intracranial aneurysm is effective in preventing long-term bleeding, but may be followed by aneurysm recurrences in a significant proportion of cases, according to...

STEMI, ultrasound to treat heart attacks, ultrasound to treat STEMI

Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 

Patients who received a bare metal coronary stent did not display significant differences in rates of adverse events with an additional 18 months of dual antiplatelet therapy rather than placebo,...

MitraClip, ACC, TVT registry, STS, Betty Vaughn

Outcomes from the initial commercial experience of transcatheter mitral valve repair (TMVR) with Abbott’s MitraClip were deemed favorable in a late-breaking clinical trial session at the American...

Biotronik, Pulsar-18, Michael Lichtenberg, study

Biotronik announced the publication of promising clinical results regarding its Pulsar-18 stent platform. Adding to the similarly encouraging data collected in the earlier 4EVER and PEACE...

Brilinta, Ticagrelor, PEGASUS TIMI-54, ACC, results

AstraZeneca announced full results from the PEGASUS-TIMI 54 study, a large-scale outcomes trial investigating Brilinta (ticagrelor) tablets plus low dose aspirin, at the American College of...

pre-operative testing, NYU Langone, guidelines

Professional physician associations consider certain routine tests before elective surgery to be of low value and high cost, and have sought to discourage their utilization. Nonetheless, a new...

Medtronic, CoreValve Evolut R, first clinical study, ACC.15

Medtronic plc announced initial clinical outcomes for its next-generation CoreValve Evolut R System at the 64th annual scientific session of the American College of Cardiology, March 14-16 in San...

Penumbra, ACE64, aspiration thrombectomy, acute ischemic stroke, FDA

Penumbra Inc. announced that the company’s ACE64 aspiration thrombectomy system received 510(k) marketing clearance from the U.S. Food and Drug Administration for the revascularization of large...

Fantom, REVA Medical, FANTOM II trial, ACC

REVA Medical Inc. announced the initiation of patient enrollment in the FANTOM II clinical trial of its Fantom sirolimus-eluting bioresorbable scaffold in March. The scaffold, made from REVA's...

CT angiography, CCTA, arterial plaque, calcification, calcium scoring, Coronary

Non-calcified arterial plaque is associated with diabetes, high systolic blood pressure and elevated “bad” cholesterol levels in asymptomatic individuals, according to a new study published online...

PRAETORIAN trial, first U.S. patients, ICD, subcutaneous, S-ICD, defibrillators

The Valley Hospital has been selected as the United States Coordinating Center for the international PRAETORIAN trial analyzing implantable cardioverter-defibrillators (ICDs). The trial will...

IABP, peer review, Maquet, Journal of Invasive Cardiology

Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of the newer, larger-capacity 50 cc intra-aortic balloon pumps (IABPs) versus...

Mitralign, six-month data, EuroPCR 2015, MPAS

Mitralign shared six-month data on its Mitralign Percutaneous Annuloplasty System (MPAS) for treatment of functional mitral regurgitation (FMR) at EuroPCR 2015 in Paris. The prospective, multi-...

CVRx, Barostim therapy, heart failure, trial, ESC-Heart Failure, Muller-Ehmsen

CVRx Inc. announced that positive results from the 'Barostim Therapy for Heart Failure' randomized, controlled clinical trial were presented at the ESC-Heart Failure 2015 Annual Conference in a...

electronic stents, bioresorbable electronic stent, BES

With the recent innovation of flexible microelectronic sensor circuits that can be made from bioresorbable materials, it is now possible to create “electronic stents” to monitor a treated lesion...

CyberHeart, Stony Brook, NSF grant, $4.2 million, Scott Smolka

A virtual-heart platform proposed by Stony Brook University researchers and colleagues has received funding from the National Science Foundation (NSF) in the amount of $4.2 million over five years...

OrbusNeich, Combo, EPC, HARMONEE study, U.S.

OrbusNeich has announced that the first U.S. patient has been enrolled in the HARMONEE (Harmonized Assessment by Randomized, Multi-center Study of OrbusNEich's COMBO StEnt) stent study. The study...

Boston Scientific, Lotus, PVL, RESPOND, REPRISE II, EuroPCR 2015

A new study evaluating the Boston Scientific Lotus Valve System demonstrated an extremely low rate of paravalvular aortic regurgitation (leakage) for a transcatheter aortic replacement valve....

At EuroPCR 2015, Mitralign presented updates on its mitral and tricuspid valve repair systems, including a presentation on six-month data on its Mitral system.